Markets
MarketMind AI
Baskets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Price History/Seasonality
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
(1)
About
Cohance Lifesciences Ltd.
NSE: COHANCE
|
BSE: 543064
|
ISIN: INE03QK01018
|
Industry: Pharmaceuticals
|
Expensive Underperformer
299.2500
0.00
(
0.00
%)
NSE
Mar 20, 2026
15:31 PM
76.06% Fall from 52W High
Volume:
515.0K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Cohance Lifesciences Ltd.
15 Mar 2023
SUVEN PHARMACEUTICALS LIMITED
Hold:
Cohance Lifesciences Ltd.
by
Geojit BNP Paribas
Target: 504
Target
Geojit BNP Paribas
Number of MF schemes decreased from 30 to 24 in Dec 2025 qtr
More from Cohance Lifesciences Ltd.
Recommended
Five Interesting Stocks Today - March 20, 2026
The Baseline |
20 Mar 2026, 06:08PM
Running strait into trouble: the oil shock hits India hard
The Baseline |
20 Mar 2026, 05:25PM
Five stocks to buy from analysts this week - March 20, 2026
The Baseline |
20 Mar 2026, 05:22PM